Monitor for future purchase orders from Israel Railways beyond the initial 15 stations and watch for any exercise of the $1 million investment option, which would dilute BiomX's ownership in Zorronet. The lack of minimum purchase obligations and termination clause limit near-term revenue visibility.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 17 $1.84entry
- T+1 · 7mo ago −20.65%α −20.46% · $1.46
- T+5 · 7mo ago −39.67%α −40.23% · $1.11
- T+20 · 6mo ago −68.26%α −73.63% · $0.5840
- T+60 · 4mo ago −88.59%α −94.73% · $0.2100
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BiomX subsidiary Zorronet secured a framework supply agreement with Israel Railways to deploy AI-powered animal detection and deterrence systems following a successful pilot that achieved 98% effectiveness. The agreement covers maintenance of 15 existing stations with potential for expansion, but includes no minimum purchase obligations and allows Israel Railways to terminate with 30 days' notice. Israel Railways also holds an unexercised option to invest $1 million for a 20% stake in Zorronet.
Key Facts
- Zorronet (BiomX subsidiary) entered into a framework supply agreement with Israel Railways for AI-powered animal detection and deterrence systems
- Agreement follows a successful pilot that achieved 98% success rate in keeping animals off railway tracks
- Initial phase covers maintenance of 15 existing alert stations with potential for additional orders at Israel Railways' discretion
- Israel Railways has unexercised option to invest $1 million for 20% of Zorronet
- Agreement has 12-month initial term with Israel Railways holding sole option to extend for another 12 months
- Israel Railways can terminate agreement for any reason with 30 days' notice
Financial Impact
Pilot investment of approximately $266,000; no specific contract value disclosed for the framework agreement
Risk Factors
- No minimum purchase obligations beyond existing 15 stations
- Israel Railways can terminate agreement with 30 days' notice
- Potential dilution of BiomX's ownership in Zorronet if investment option is exercised
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-044722 |
| Document: ea028664701ex99-1_biomx.htm | 0001213900-26-044722 |
| Document: 0001213900-26-044722-index-headers.html | 0001213900-26-044722 |
| Document: 0001213900-26-044722-index.html | 0001213900-26-044722 |
| Document: 0001213900-26-044722.txt | 0001213900-26-044722 |
Track record
22 reports on PHGE
8 of 12 bullish or bearish reports moved the stock their way by T+1. Best: +62.36% at T+20 after the Jun 16, 2026 report. 8 of 12 went positive at some point.
Filters
- Oct 7, 20265w ago 8-K Neutral 4/10 Entry $0.3092 to $0.2915 ▼ −5.72% −5.30% vs SPY
- Oct 7, 20265w ago DEF 14A Bearish 6/10 Entry $0.3092 to $0.2915 ▲ +5.72% +5.30% vs SPY
- Sep 1, 202610w ago 8-K Neutral 3/10 Entry $0.1425 to $0.1421 ▼ −0.28% −1.33% vs SPY
- Aug 28, 202611w ago 8-K Neutral 4/10 Entry $0.1371 to $0.1430 ▲ +4.30% +4.99% vs SPY
- Aug 5, 202614w ago Press Release Bearish 5/10 Entry $0.1800 to $0.1598 ▲ +11.22% +11.06% vs SPY
- Jul 28, 202615w ago 8-K Bearish 8/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 28, 202615w ago Press Release Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 27, 202616w ago 424B5 Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 8, 202618w ago Press Release Neutral 4/10 Entry $0.2758 to $0.2800 ▲ +1.52% +0.68% vs SPY
- Jul 2, 202619w ago 8-K Bearish 6/10 Entry $0.3190 to $0.3020 ▲ +5.33% +6.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers